secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2026-09-01T21:13:23+00:00
Accession:  0001104659-26-104368
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Biotherapeutics: Court sanctions scheme; merger effective Sept 9, trading halt ahead
--------------------------------------------------------------------------------

- Court sanctioned Scheme of Arrangement and share premium capital reduction on Sept 1, 2026.
- Scheme expected to become effective Sept 9, 2026; ADS trading halt expected before open that day.
- Merger with Clywedog Therapeutics (per Sept 29, 2025 agreement) on track; delisting/deregistration plans unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/0001104659-26-104368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/tm2624619d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-104368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer